A parallel controlled, single-center clinical study of the efficacy and safety of a novel ophthalmonic viscosurgical device-free ICL implantation technique under anterior chamber perfusion

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049644

Enrollment

Unknown

Registered

2021-08-07

Start date

2021-08-16

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

experimental group:Viscoelastic-free ICL implantation under full anterior chamber perfusion in one eye, traditional ICL implantation with viscoelastic in the other eye

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Myopic patients with preoperative best corrected visual acuity higher than or equal to 0logMAR; 2. Myopia range: -1.0D - -18D 3. Corneal astigmatism <= 1.0D; 4. Pupil diameter greater than 3.0mm under medium illumination; 5. Follow up regularly.

Exclusion criteria

Exclusion criteria: With glaucoma, old iritis, corneal disease, fundus disease, optic nerve disease and other eye diseases.

Design outcomes

Primary

Measure	Time frame
intraocular pressure;uncorrected distance visual acuity;best-corrected distance visual acuity;equivalent spherical degree;visual quality index;subjective visual quality scale;corneal endothelial cell density;operation time;	—

Countries

China

Contacts

Public ContactQin Qin

The Affiliated Hospital of Nanjing University Medical School

qinqin.1219@hotmail.com+86 15005161908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026